Kenneth L. Meredith, MD

BOARD CERTIFICATION:
          •  Surgery

FELLOWSHIP:
          •  H. Lee Moffitt Cancer Center & Research Institute - Surgical Oncology
          •  University of Wisconsin Hospital and Clinics - Surgical Oncology

RESIDENCY:
          •  University of Wisconsin Hospital and Clinics - Surgery

MEDICAL SCHOOL:
          •  University of Louisville School of Medicine - MD

• Shridhar R, Weber J, Hoffe SE, Almhanna K, Karl R, Meredith K. Adjuvant Radiation Therapy and Lymphadenectomy in Esophageal Cancer: A SEER Database Analysis. J Gastrointest Surg. 2013 Jun. Pubmedid: 23749498.


• Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, Scott WJ, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD, McMillian NR, Sundar H. Gastric Cancer, Version 2.2013. J Natl Compr Canc Netw. 2013 May;11(5):531-546. Pubmedid: 23667204.


• Hernandez JM, Dimou F, Weber J, Almhanna K, Hoffe S, Shridhar R, Karl R, Meredith K. Defining the Learning Curve for Robotic-assisted Esophagogastrectomy. J Gastrointest Surg. 2013 May. Pubmedid: 23690208.


• Chuong MD, Fernandez DC, Shridhar R, Hoffe SE, Saini A, Hunt D, Meredith KL, Biagioli MC. High-dose-rate endorectal brachytherapy for locally advanced rectal cancer in previously irradiated patients. Brachytherapy. 2013 May. Pubmedid: 23707855.


• Shridhar R, Almhanna K, Hoffe SE, Fulp W, Weber J, Chuong MD, Meredith KL. Increased survival associated with surgery and radiation therapy in metastatic gastric cancer: A Surveillance, Epidemiology, and End Results database analysis. Cancer. 2013 May;119(9):1636-1642. Pubmedid: 23361968.


• Yamamoto M, Weber JM, Karl RC, Meredith KL. Minimally invasive surgery for esophageal cancer: review of the literature and institutional experience. Cancer Control. 2013 Apr;20(2):130-137. Pubmedid: 23571703.


• McLoughlin JM, Lewis JM, Meredith KL. The impact of age on morbidity and mortality following esophagectomy for esophageal cancer. Cancer Control. 2013 Apr;20(2):144-150. Pubmedid: 23571705.


• de la Fuente SG, Weber J, Hoffe SE, Shridhar R, Karl R, Meredith KL. Initial experience from a large referral center with robotic-assisted Ivor Lewis esophagogastrectomy for oncologic purposes. Surg Endosc. 2013 Apr. Pubmedid: 23549761.


• Shridhar R, Almhanna K, Meredith KL, Biagioli MC, Chuong MD, Cruz A, Hoffe SE. Radiation therapy and esophageal cancer. Cancer Control. 2013 Apr;20(2):97-110. Pubmedid: 23571700.


• Wong JY, Shridhar R, Almhanna K, Hoffe SE, Karl RC, Meredith KL. The impact of body mass index on esophageal cancer. Cancer Control. 2013 Apr;20(2):138-143. Pubmedid: 23571704.


• Vignesh S, Hoffe SE, Meredith KL, Shridhar R, Almhanna K, Gupta AK. Endoscopic Therapy of Neoplasia Related to Barrett's Esophagus and Endoscopic Palliation of Esophageal Cancer. Cancer Control. 2013 Apr;20(2):117-129. Pubmedid: 23571702.


• Almhanna K, Meredith KL, Hoffe SE, Shridhar R, Coppola D. Targeting the human epidermal growth factor receptor 2 in esophageal cancer. Cancer Control. 2013 Apr;20(2):111-116. Pubmedid: 23571701.


• Almhanna K, Shridhar R, Meredith KL. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: is there a standard of care?. Cancer Control. 2013 Apr;20(2):89-96. Pubmedid: 23571699.


• Chuong MD, Springett GM, Freilich JM, Park CK, Weber JM, Mellon EA, Hodul PJ, Malafa MP, Meredith KL, Hoffe SE, Shridhar R. Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated. Int J Radiat Oncol Biol Phys. 2013 Apr;86(3):516-522. Pubmedid: 23562768.


• Meredith KL. Gone fishing. Cancer Control. 2013 Apr;20(2):84-86. Pubmedid: 23571698.


• Shridhar R, Hoffe SE, Almhanna K, Weber JM, Chuong MD, Karl RC, Meredith K. Lymph Node Harvest in Esophageal Cancer After Neoadjuvant Chemoradiotherapy. Ann Surg Oncol. 2013 Apr. Pubmedid: 23625142.


• Chuong MD, Freilich JM, Hoffe SE, Fulp W, Weber JM, Almhanna K, Dinwoodie W, Rao N, Meredith KL, Shridhar R. Intensity-Modulated Radiation Therapy vs. 3D Conformal Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal. Gastrointest Cancer Res. 2013 Mar;6(2):39-45. Pubmedid: 23745158. Pmcid: PMC3674462.


• Pimiento JM, Weber J, Hoffe SE, Shridhar R, Almhanna K, Vignesh S, Karl RC, Meredith KL. Outcomes Associated with Surgery for T4 Esophageal Cancer. Ann Surg Oncol. 2013 Mar. Pubmedid: 23504118.


• Strosberg JR, Weber JM, Feldman M, Coppola D, Meredith K, Kvols LK. Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors. J Clin Oncol. 2013 Feb;31(4):420-425. Pubmedid: 23248248.


• Melis M, Weber J, Shridhar R, Hoffe S, Almhanna K, Karl RC, Meredith KL. Body mass index and perioperative complications after oesophagectomy for adenocarcinoma: a systematic database review. BMJ Open. 2013;3(5). Pubmedid: 23645908. Pmcid: PMC3646172.


• Shridhar R, Hayman T, Hoffe SE, Weber J, Almhanna K, Chuong M, Karl RC, Meredith KL. Body mass index and survival in esophageal adenocarcinoma treated with chemoradiotherapy followed by esophagectomy. J Gastrointest Surg. 2012 Jul;16(7):1296-1302. Pubmedid: 22399271.


• Shridhar R, Dombi GW, Weber J, Hoffe SE, Meredith K, Konski A. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis. Am J Clin Oncol. 2012 Jun;35(3):216-221. Pubmedid: 21378540.


• Dittrick GW, Weber JM, Shridhar R, Hoffe S, Melis M, Almhanna K, Barthel J, McLoughlin J, Karl RC, Meredith KL. Pathologic Nonresponders after Neoadjuvant Chemoradiation for Esophageal Cancer Demonstrate no Survival Benefit Compared with Patients Treated with Primary Esophagectomy. Ann Surg Oncol. 2012 May;19(5):1678-1684. Pubmedid: 22045465.


• Shridhar R, Dombi GW, Finkelstein SE, Meredith KL, Hoffe SE. Improved survival in patients with lymph node-positive gastric cancer who received preoperative radiation: an analysis of the Surveillance, Epidemiology, and End Results database. Cancer. 2011 Sep;117(17):3908-3916. Pubmedid: 21365627.


• Barthel JS, Kucera S, Harris C, Canchi D, Hoffe S, Meredith K. Cryoablation of persistent Barrett's epithelium after definitive chemoradiation therapy for esophageal adenocarcinoma. Gastrointest Endosc. 2011 Jul;74(1):51-57. Pubmedid: 21549371.


• Melis M, Weber JM, McLoughlin JM, Siegel EM, Hoffe S, Shridhar R, Turaga KK, Dittrick G, Dean EM, Karl RC, Meredith KL. An elevated body mass index does not reduce survival after esophagectomy for cancer. Ann Surg Oncol. 2011 Mar;18(3):824-831. Pubmedid: 20865331.


• Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G. Gastric cancer. J Natl Compr Canc Netw. 2010 Apr;8(4):378-409. Pubmedid: 20410333.


• Meredith KL, Weber JM, Turaga KK, Siegel EM, McLoughlin J, Hoffe S, Marcovalerio M, Shah N, Kelley S, Karl R. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer. Ann Surg Oncol. 2010 Apr;17(4):1159-1167. Pubmedid: 20140529.


• Meredith KL, Hoffe SE, Shibata D. The multidisciplinary management of rectal cancer. Surg Clin North Am. 2009 Feb;89(1):177-215. Pubmedid: 19186236.


• Santillan A, Farma J, Meredith K, Shah N, Kelley S. Minimally invasive surgery for esophageal cancer. J Natl Compr Canc Netw. 2008 Oct;6(9):879-884. Pubmedid: 18926097.


• Mahvi D, Henry M, Albertini M, Weber S, Meredith K, Schalch H, RakhmilevichA, Hank J, Sondel P. Intratumoral injection of IL-12 plasmid DNA--results of a phase I/IB clinical trial. Cancer Gene Ther. 2007 Aug;14(8):717-723. Pubmedid: 17557109.


• Meredith K, Haemmerich D, Qi C, Mahvi D. Hepatic resection but not radiofrequency ablation results in tumor growth and increased growth factor expression. Ann Surg. 2007 May;245(5):771-776. Pubmedid: 17457170. Pmcid: PMC1877067.


• Meredith K, Lee F, Henry M, Warner T, Mahvi D. Microwave ablation of hepatic tumors using dual-loop probes: results of a phase I clinical trial. J Gastrointest Surg. 2005 Dec;9(9):1354-1360. Pubmedid: 16332494.


• Tangwongsan C, Will JA, Webster JG, Meredith KL, Mahvi DM. In vivo measurement of swine endocardial convective heat transfer coefficient. IEEE Trans Biomed Eng. 2004 Aug;51(8):1478-1486. Pubmedid: 15311835.


• Shock S, Meredith K, Warner T, Sampson L, Wright A, Winter TC 3rd, MahviDM, Fine J, Lee FT J. Microwave ablation with loop antenna: in vivo porcine liver model. Radiology. 2004 Apr;231(1):143-149. Pubmedid: 14990816.

Dr. Kenneth Meredith is surgical oncologist and head of the section of Esophagogastric Oncology in the Gastrointestinal Oncology Department at Moffitt Cancer Center.  He is an assistant professor in the Department of Surgery and the Department of Oncologic Sciences at the University of South Florida’s College of Medicine.
Dr. Meredith's clinical interests include surgical and multidisciplinary management of primary and metastic tumors of the colon, rectum and esophagus. He has specialized training in robotic, laparoscopic and minimally invasive colorectal and esophageal surgery, transanal rectal surgery, total mesorectal excision, colonic J-pouch reconstruction and sphincter-preserving surgery.  His current research focuses on molecular mechanisms involved in colorectal and esophageal cancer and the development of prognostic and predictive gene signatures for both primary and metastatic gastrointestinal malignancies.
Dr. Meredith received his medical degree from the University of Louisville School of Medicine in Louisville, KY., graduating with the dean’s award for academic excellence.  He completed residencies in surgery at the University of Wisconsin Hospital and Clinics, serving as chief resident his last year.   He then pursued additional training at Moffitt with a clinical fellowship in surgical oncology, followed by a research fellowship in surgical oncology.
Dr. Meredith received an American Society of Clinical Oncology Gastrointestinal Oncology Conquer Cancer Foundation Grant in 2012.  He serves on the National Comprehensive Cancer Network Guidelines Panel for Esophageal Cancer and Gastric Cancer. Additionally, he is an ad hoc journal reviewer for numerous professional publications.